UA92310C2 - Composition comprising nateglinide, lactose monohydrate and microcrystalline cellulose - Google Patents

Composition comprising nateglinide, lactose monohydrate and microcrystalline cellulose

Info

Publication number
UA92310C2
UA92310C2 UAA200600286A UAA200600286A UA92310C2 UA 92310 C2 UA92310 C2 UA 92310C2 UA A200600286 A UAA200600286 A UA A200600286A UA A200600286 A UAA200600286 A UA A200600286A UA 92310 C2 UA92310 C2 UA 92310C2
Authority
UA
Ukraine
Prior art keywords
nateglinide
composition
microcrystalline cellulose
lactose monohydrate
free
Prior art date
Application number
UAA200600286A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Марджери Реган Гатлин
Мишель Понговски
Ричард Оуэн Меннион
Аниз Абдулквадар Карнахи
Кристиан Гюитард
Малькольм Аллисон
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of UA92310C2 publication Critical patent/UA92310C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates a composition comprising nateglinide in free or pharmaceutically acceptable salt form, lactose monohydrate and microcrystalline cellulose in specified amounts.
UAA200600286A 1999-09-17 2000-09-15 Composition comprising nateglinide, lactose monohydrate and microcrystalline cellulose UA92310C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39836499A 1999-09-17 1999-09-17

Publications (1)

Publication Number Publication Date
UA92310C2 true UA92310C2 (en) 2010-10-25

Family

ID=32595038

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200600286A UA92310C2 (en) 1999-09-17 2000-09-15 Composition comprising nateglinide, lactose monohydrate and microcrystalline cellulose

Country Status (4)

Country Link
CN (1) CN101002758B (en)
EC (1) ECSP003659A (en)
UA (1) UA92310C2 (en)
ZA (2) ZA200309946B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107898788A (en) * 2017-11-08 2018-04-13 罗昌兴 A kind of hypoglycemic pharmaceutical composition and preparation method thereof

Also Published As

Publication number Publication date
CN101002758A (en) 2007-07-25
ZA200309946B (en) 2005-03-15
ECSP003659A (en) 2002-04-23
ZA200202107B (en) 2004-02-11
CN101002758B (en) 2010-12-01

Similar Documents

Publication Publication Date Title
EP1178786A4 (en) Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
HK1050367A1 (en) Pharmaceutically active compounds.
IL153508A0 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
HUP0402113A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, preparation and use thereof
IL143349A0 (en) Azepinoindole derivatives, the production and use thereof
HK1048306A1 (en) Pharmaceutically active sulfonamide derivatives.
MX9802383A (en) Pyrimidine derivatives as 5ht2c-receptor antagonists.
AU2001262318A1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
MXPA02006325A (en) Precutter and edger machine.
ZA200200222B (en) Titanium derived compounds, preparation and use thereof.
GC0000113A (en) Eletriptan hydrobromide monohydrate.
ZA200309114B (en) Disodium salts, monohydrates and ethanol solvates.
AU2298200A (en) Stabilized filler, its production and use
ZA200203170B (en) Mutant luciferase.
BG106031A (en) Prucalopride oral solution
MXPA01011720A (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods.
UA92310C2 (en) Composition comprising nateglinide, lactose monohydrate and microcrystalline cellulose
AU2001232332A1 (en) Leptin-resistance ameliorating agents
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
AU6846300A (en) Use of cyamemazine for cold turkey benzodiazepine treatment
GEP20094649B (en) Orodispersible pharmaceutical composition of an antithrombotic compound
GB9802542D0 (en) New use
AU2001213286A1 (en) Multi-valve delivery system
ZA200001747B (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use.
PH12001001922B1 (en) Crystalline therapeutic agent.